Weibin Shi
- Molecular Biology
- Biomedical Engineering top 10%
- Biomaterials top 5%
- Cancer Research top 10%
- Oncology
- Co-authors
- Jianwen LiuXin LiangMeidong LangJing DingPeng YangChangchun WangJia GuoSha Jin
- Topics
- Nanoparticle-Based Drug Delivery (7 papers)MicroRNA in disease regulation (6 papers)Circular RNAs in diseases (6 papers)
In The Last Decade
Weibin Shi
29 papers receiving 748 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 294
- Biomedical Engineering 260
- Biomaterials 228
- Cancer Research 219
- Oncology 98
Countries citing papers authored by Weibin Shi
This map shows the geographic impact of Weibin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibin Shi more than expected).
Fields of papers citing papers by Weibin Shi
This network shows the impact of papers produced by Weibin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibin Shi. The network helps show where Weibin Shi may publish in the future.
Co-authorship network of co-authors of Weibin Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Weibin Shi. A scholar is included among the top collaborators of Weibin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weibin Shi. Weibin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 20 | |
| 3 | 9 | |
| 4 | 14 | |
| 5 | 11 | |
| 6 | 49 | |
| 7 | 26 | |
| 8 | 72 | |
| 9 | 22 | |
| 10 | 11 | |
| 11 | 18 | |
| 12 | 17 | |
| 13 | 114 | |
| 14 | 7 | |
| 15 | 12 | |
| 16 | 6 | |
| 17 | 10 | |
| 18 | 1 | |
| 19 | 91 | |
| 20 | 1 |
About Weibin Shi
Weibin Shi is a scholar working on Biomaterials, Cancer Research and Toxicology, having authored 30 papers that have together received 756 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Biomaterials (228 citations), Cancer Research (219 citations) and Molecular Medicine (33 citations). Weibin Shi has collaborated with scholars based in China, Australia and Japan. Frequent co-authors include Jianwen Liu, Xin Liang, Meidong Lang, Jing Ding, Peng Yang, Changchun Wang, Jia Guo, Sha Jin, Vanminh Le and Yixin Wu. Their work appears in journals such as Biomaterials, Chemistry of Materials and Langmuir.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.